Clinical characteristics of study patients
Patient | Age | Sex | FEV1 (% pred) | PC20 hist (mg/ml) | Skin test* | Rhinitis | Medication asthma | Medication rhinitis |
---|---|---|---|---|---|---|---|---|
*X times histamine reaction. | ||||||||
B=beclomethasone or budesonide; F=fluticasone; SB=salbutamol; SM=salmeterol; FO=formeterol. | ||||||||
Placebo group | ||||||||
1 | 21 | M | 97 | 1.76 | 2.1 | – | B, SB | – |
2 | 11 | M | 79 | 0.74 | 1.1 | + | B, SB | – |
3 | 11 | M | 97 | 4.00 | 1.4 | + | B, SB | – |
4 | 29 | M | 81 | 0.33 | 1.2 | – | F, SM | – |
5 | 21 | M | 73 | 2.43 | 2.0 | + | B, SB | B |
6 | 27 | F | 70 | 0.90 | 1.2 | + | B, SB | B |
7 | 44 | M | 70 | 1.89 | 1.2 | + | F, SM | F |
8 | 17 | F | 138 | 1.78 | 1.9 | + | – | B |
9 | 40 | M | 64 | 1.13 | 1.6 | + | B, SB | – |
10 | 29 | M | 103 | 0.71 | 1.5 | + | – | – |
11 | 28 | F | 73 | 0.45 | 2.2 | – | F, SB | – |
12 | 12 | M | 106 | 4.00 | 1.6 | + | B, SB | – |
13 | 25 | F | 98 | 1.53 | 1.5 | + | SB | – |
14 | 30 | M | 100 | 2.90 | 1.5 | – | B, SB | – |
Mean | 25 | 89 | 1.75 | 1.6 | ||||
SD | 10 | 20 | 1.21 | 0.4 | ||||
Active group | ||||||||
1 | 25 | F | 99 | 1.19 | 1.5 | + | B, SB | – |
2 | 29 | M | 99 | 0.95 | 1.6 | – | B | – |
3 | 41 | M | 67 | 3.79 | 2.2 | + | B, SB | – |
4 | 24 | F | 86 | 2.00 | 1.8 | + | B, SB | – |
5 | 31 | M | 81 | 1.22 | 1.5 | – | – | – |
6 | 24 | M | 80 | 0.55 | 1.1 | + | B, SB | B |
7 | 22 | F | 104 | 2.67 | 1.4 | + | B | – |
8 | 51 | F | 70 | 0.45 | 1.2 | + | B, SB | B |
9 | 32 | M | 68 | 0.42 | 1.1 | – | B, SM | – |
10 | 36 | F | 103 | 0.35 | 1.8 | + | SB | B |
11 | 42 | M | 75 | 0.42 | 1.2 | – | B, SM | – |
12 | 18 | F | 103 | 2.35 | 1.2 | + | F, SM | F |
13 | 40 | F | 98 | 0.86 | 1.6 | + | B, SB | B |
14 | 30 | F | 107 | 1.16 | 1.9 | + | F, SB | F |
15 | 41 | F | 97 | 0.98 | 1.1 | – | B, SM | – |
16 | 37 | M | 76 | 0.91 | 1.3 | – | SB | – |
Mean | 33 | 88 | 1.27 | 1.5 | ||||
SD | 9 | 14 | 0.97 | 0.3 |